Skip to main content
kainos loboratories,inc logo

kainos loboratories,inc — Investor Relations & Filings

Ticker · 4556 ISIN · JP3205650009 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2016-11-02 Interim / Quarterly Rep…
Country JP Japan
Listing T 4556

About kainos loboratories,inc

https://www.kainos.co.jp/en/

Kainos Laboratories, Inc. is a company focused on the development, manufacture, marketing, and distribution of in-vitro diagnostics and pharmaceuticals. As a pioneer in its field, the company specializes in creating innovative clinical testing reagents for biochemical, immunological, and genetic analysis. These diagnostic tools are used to examine biological samples, such as blood and urine, to provide data on a patient's health status. The company is committed to developing and supplying novel products to meet the needs of the medical and healthcare communities.

Recent filings

Filing Released Lang Actions
四半期報告書－第42期第2四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the company 'KAINOS Laboratories, Inc.' covering the second quarter of the 42nd fiscal period (April 1, 2016 to September 30, 2016). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as notes to the financial statements and management analysis. This fits the definition of an Interim/Quarterly Report (IR). H1 2017
2016-11-02 Japanese
四半期報告書－第42期第1四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '第１四半期報告書' (First Quarter Report) for KAINOS Laboratories, Inc. It contains detailed financial statements (Balance Sheet, Income Statement), notes to the financial statements, and management analysis for the first quarter of the fiscal year ending March 31, 2017. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2017
2016-08-03 Japanese
有価証券報告書－第41期(2015/04/01－2016/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion and analysis (MDA), and business overview for the fiscal year ending March 31, 2016. This corresponds to the 10-K equivalent in the provided classification schema. FY 2016
2016-06-17 Japanese
四半期報告書－第41期第3四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 41st fiscal period of KAINOS Laboratories, Inc. It contains detailed financial statements (balance sheet, income statement), notes to financial statements, and management analysis. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2016
2016-02-02 Japanese
四半期報告書－第41期第2四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement for the second quarter of the 41st fiscal period. It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2015-11-02 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.